Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 1/2011

01-02-2011

Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation

Authors: Amr Abdelbaky, Ahmed Tawakol

Published in: Current Cardiovascular Imaging Reports | Issue 1/2011

Login to get access

Abstract

The importance of inflammation to atherothrombosis has led to the pursuit of noninvasive imaging methods to measure inflammation within the arterial wall. There is substantial evidence supporting the use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging for evaluation of atherosclerotic plaque inflammation. However, coronary imaging with this technique has been limited, due to several technical hurdles. Nonetheless, early experiences in coronary FDG-PET imaging have been encouraging. This review outlines the development of vascular PET imaging and its potential use for evaluation of coronary artery disease.
Literature
1.
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–71.PubMed
2.
3.
Kovanen PT. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques. Biochem Soc Trans 2007;35:857–61.CrossRefPubMed
4.
Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008;263:517–27.CrossRefPubMed
5.
Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clinical Cardiology 2000;23 Suppl 6:VI-3-7.PubMed
6.
Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252:283–94.CrossRefPubMed
7.
Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763–71.CrossRefPubMed
8.
Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003;41:37S–42S.CrossRefPubMed
9.
Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276–82.CrossRefPubMed
10.
Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316–25.CrossRefPubMed
11.
Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 2003;30:267–73.CrossRefPubMed
12.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–80.PubMed
13.
Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104–12.PubMed
14.
Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001;26:314–9.CrossRefPubMed
15.
Shepherd PR, Kahn BB. Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248–57.CrossRefPubMed
16.
Leppanen O, Bjornheden T, Evaldsson M, Boren J, Wiklund O, Levin M. ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis 2006;188:323–30.CrossRefPubMed
17.
Bjornheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999;19:870–6.PubMed
18.
Mayr M, Sidibe A, Zampetaki A. The paradox of hypoxic and oxidative stress in atherosclerosis. J Am Coll Cardiol 2008;51:1266–7.CrossRefPubMed
19.
Evans WH, Karnovsky ML. The biochemical basis of phagocytosis. IV. Some aspects of carbohydrate metabolism during phagocytosis. Biochemistry 1962;1:159–66.CrossRefPubMed
20.
Weisdorf DJ, Craddock PR, Jacob HS. Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation 1982;6:245–56.CrossRefPubMed
21.
Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009;218:7–29.CrossRefPubMed
22.
Strauss HW, Dunphy M, Tokita N. Imaging the vulnerable plaque: a scintillating light at the end of the tunnel? J Nucl Med 2004;45:1106–7.PubMed
23.
Ogawa M, Ishino S, Mukai T, et al. 18F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245–50.PubMed
24.
Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med 2009;50:959–65.CrossRefPubMed
25.
Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294–301.CrossRefPubMed
26.
Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 2008;117:2061–70.CrossRefPubMed
27.
Ogawa M, Magata Y, Kato T, et al. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med 2006;47:1845–50.PubMed
28.
Davies JR, Izquierdo-Garcia D, Rudd JH, et al. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. Int J Cardiovasc Imaging 2010;26:41–8.CrossRefPubMed
29.
Worthley SG, Zhang ZY, Machac J, et al. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging 2009;25:251–7.CrossRefPubMed
30.
Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice. J Nucl Med 2008;49:1707–14.CrossRefPubMed
31.
Bural GG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2008;35:562–9.CrossRefPubMed
32.
Joly L, Djaballah W, Koehl G, et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging 2009;36:979–85.CrossRefPubMed
33.
Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107–15.CrossRefPubMed
34.
Kim TN, Kim S, Yang SJ, et al. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging 2010;3:142–8.CrossRefPubMed
35.
Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010;3:388–97.CrossRefPubMed
36.
Wu YW, Kao HL, Chen MF, et al. Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007;48:227–33.PubMed
37.
Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–11.CrossRefPubMed
38.
•• Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009;50:1611–20. This article provides evidence that patients with large blood vessels that contain foci of high FDG uptake have a high risk of subsequent atherothrombotic events. CrossRefPubMed
39.
Graebe M, Pedersen SF, Borgwardt L, Hojgaard L, Sillesen H, Kjaer A. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg 2009;37:714–21.CrossRefPubMed
40.
Pedersen SF, Graebe M, Fisker Hag AM, Hojgaard L, Sillesen H, Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010;31:423–9.PubMed
41.
Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.CrossRefPubMed
42.
Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50:892–6.CrossRefPubMed
43.
•• Rudd JH, Myers KS, Bansilal S, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 2008;49:871–8. This paper demonstrates that PET measures of vascular FDG uptake are highly reproducible. CrossRefPubMed
44.
Izquierdo-Garcia D, Davies JR, Graves MJ, et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke 2009;40:86–93.CrossRefPubMed
45.
Font MA, Fernandez A, Carvajal A, et al. Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci 2009;14:3352–60.CrossRefPubMed
46.
Lee SJ, On YK, Lee EJ, Choi JY, Kim BT, Lee KH. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med 2008;49:1277–82.CrossRefPubMed
47.
Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825–31.CrossRefPubMed
48.
clinicaltrials.gov. (Accessed at clinicaltrials.gov.)
49.
Dunphy MP, Freiman A, Larson SM, Strauss HW. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 2005;46:1278–84.PubMed
50.
Alexanderson E, Slomka P, Cheng V, et al. Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol 2008;15:841–3.PubMed
51.
52.
de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98–101.CrossRefPubMed
53.
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77PubMed
54.
Williams G, Kolodny GM. Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study. Nucl Med Commun 2009;30:287–91.CrossRefPubMed
55.
Wykrzykowska J, Lehman S, Williams G, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563–8.CrossRefPubMed
56.
• Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of 18-fluorodeoxyglucose imaging of the coronary arteries: Comparison between patients with acute coronary syndromes and stable angina. JACC Cardiovascular Imaging 2010; 3;388–397. This article demonstrates with FDG-PET imaging that atherosclerotic inflammatory activity is increased in coronary culprit lesions after ACS. CrossRefPubMed
57.
Elmaleh DR, Fischman AJ, Tawakol A, et al. Detection of inflamed atherosclerotic lesions with diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci U S A 2006;103:15992–6.CrossRefPubMed
58.
Laitinen I, Saraste A, Weidl E, et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2009;2:331–8.CrossRefPubMed
59.
Matter CM, Wyss MT, Meier P, et al. 18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler Thromb Vasc Biol 2006;26:584–9.CrossRefPubMed
60.
Laitinen IE, Luoto P, Nagren K, et al. Uptake of 11C-choline in mouse atherosclerotic plaques. J Nucl Med 2010;51:798–802.CrossRefPubMed
61.
Calcagno C, Cornily JC, Hyafil F, et al. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol 2008;28:1311–7.CrossRefPubMed
62.
Isobe S, Tsimikas S, Zhou J, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 2006;47:1497–505.PubMed
63.
Suzuki Y, Slomka PJ, Wolak A, et al. Motion-frozen myocardial perfusion SPECT improves detection of coronary artery disease in obese patients. J Nucl Med 2008;49:1075–9.CrossRefPubMed
64.
Muller JE, Tawakol A, Kathiresan S, Narula J. New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques. Journal of the American College of Cardiology 2006;47:C2–6.CrossRefPubMed
65.
Sheikine Y, Akram K. FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis 2010;211:371–80.CrossRefPubMed
66.
Rudd JH, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? Journal of the American College of Cardiology 2010;55:2527–35.CrossRefPubMed
67.
Metadata
Title
Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation
Authors
Amr Abdelbaky
Ahmed Tawakol
Publication date
01-02-2011
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 1/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-010-9062-4

Other articles of this Issue 1/2011

Current Cardiovascular Imaging Reports 1/2011 Go to the issue

ReviewPaper

Molecular Imaging of Healing After Myocardial Infarction

ReviewPaper

Cellular and Functional Imaging of Cardiac Transplant Rejection

ReviewPaper

Imaging Myeloperoxidase Activity in Cardiovascular Disease

ReviewPaper

Molecular MRI of Thrombosis

ReviewPaper

Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques

ReviewPaper

Microparticle-Based Molecular MRI of Atherosclerosis, Thrombosis, and Tissue Ischemia